72 related articles for article (PubMed ID: 23298674)
1. Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.
Wang T; Kievit FM; Veiseh O; Arami H; Stephen ZR; Fang C; Liu Y; Ellenbogen RG; Zhang M
World Neurosurg; 2013; 80(1-2):134-41. PubMed ID: 23298674
[TBL] [Abstract][Full Text] [Related]
2. A pretargeted nanoparticle system for tumor cell labeling.
Gunn J; Park SI; Veiseh O; Press OW; Zhang M
Mol Biosyst; 2011 Mar; 7(3):742-8. PubMed ID: 21107453
[TBL] [Abstract][Full Text] [Related]
3. Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery.
Hsiao MH; Mu Q; Stephen ZR; Fang C; Zhang M
ACS Macro Lett; 2015 Apr; 4(4):403-407. PubMed ID: 26900510
[TBL] [Abstract][Full Text] [Related]
4. Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles.
Lin R; Li Y; MacDonald T; Wu H; Provenzale J; Peng X; Huang J; Wang L; Wang AY; Yang J; Mao H
Colloids Surf B Biointerfaces; 2017 Feb; 150():261-270. PubMed ID: 28029547
[TBL] [Abstract][Full Text] [Related]
5. Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells.
Carney CP; Pandey N; Kapur A; Saadi H; Ong HL; Chen C; Winkles JA; Woodworth GF; Kim AJ
ACS Nano; 2023 Oct; 17(20):19667-19684. PubMed ID: 37812740
[TBL] [Abstract][Full Text] [Related]
6. PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection.
Kievit FM; Veiseh O; Bhattarai N; Fang C; Gunn JW; Lee D; Ellenbogen RG; Olson JM; Zhang M
Adv Funct Mater; 2009 Jul; 19(14):2244-2251. PubMed ID: 20160995
[TBL] [Abstract][Full Text] [Related]
7. Heterobifunctional PEG ligands for bioconjugation reactions on iron oxide nanoparticles.
Bloemen M; Van Stappen T; Willot P; Lammertyn J; Koeckelberghs G; Geukens N; Gils A; Verbiest T
PLoS One; 2014; 9(10):e109475. PubMed ID: 25275378
[TBL] [Abstract][Full Text] [Related]
8. Cell Size as a Primary Determinant in Targeted Nanoparticle Uptake.
Howard D; Turnbull T; Paterson DJ; Thierry B; Kempson I
ACS Appl Bio Mater; 2022 Aug; ():. PubMed ID: 36027561
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Impact of Nanoparticle Stealth Coatings in Cancer Models: From PEGylation to Cell Membrane-Coating Nanotechnology.
Graván P; Peña-Martín J; de Andrés JL; Pedrosa M; Villegas-Montoya M; Galisteo-González F; Marchal JA; Sánchez-Moreno P
ACS Appl Mater Interfaces; 2024 Jan; 16(2):2058-2074. PubMed ID: 38159050
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Cellular Uptake Studies of Self-Assembled Fluorinated Nanoparticles Labelled with Antibodies.
Atabakhshi-Kashi M; Carril M; Mahdavi H; Parak WJ; Carrillo-Carrion C; Khajeh K
Nanomaterials (Basel); 2021 Jul; 11(8):. PubMed ID: 34443736
[TBL] [Abstract][Full Text] [Related]
11. Microwave-Assisted Synthesis of Carbon Dot - Iron Oxide Nanoparticles for Fluorescence Imaging and Therapy.
Chung S; Zhang M
Front Bioeng Biotechnol; 2021; 9():711534. PubMed ID: 34295883
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilization of Magnetic Nanoparticles with Modified Alternating Copolymers. Part 1: The Influence of the Grafting.
Bronstein LM; Shtykova EV; Malyutin A; Dyke JC; Gunn E; Gao X; Stein B; Konarev PV; Dragnea B; Svergun DI
J Phys Chem C Nanomater Interfaces; 2010 Dec; 114(50):21900-21907. PubMed ID: 21221425
[TBL] [Abstract][Full Text] [Related]
13. Development of a contacting transwell co-culture system for the
Nishi M; Tateishi K; Sundararaj JS; Ino Y; Nakai Y; Hatayama Y; Yamaoka Y; Mihana Y; Miyakawa K; Kimura H; Kimura Y; Yamamoto T; Ryo A
Front Cell Dev Biol; 2023; 11():1275519. PubMed ID: 38089883
[TBL] [Abstract][Full Text] [Related]
14. Can targeted nanoparticles distinguish cancer metastasis from inflammation?
Choi AS; Moon TJ; Abuhashim W; Bhalotia A; Qian H; Paulsen KE; Lorkowski M; Ndamira C; Gopalakrishnan R; Krishnamurthy A; Schiemann WP; Karathanasis E
J Control Release; 2023 Oct; 362():812-819. PubMed ID: 37011838
[TBL] [Abstract][Full Text] [Related]
15. Linker-free conjugation and specific cell targeting of antibody functionalized iron-oxide nanoparticles.
Xu Y; Baiu DC; Sherwood JA; McElreath MR; Qin Y; Lackey KH; Otto M; Bao Y
J Mater Chem B; 2014 Oct; 2(37):6198-6206. PubMed ID: 26660881
[TBL] [Abstract][Full Text] [Related]
16. Interactions between nanoparticle corona proteins and the immune system.
Tran TT; Roffler SR
Curr Opin Biotechnol; 2023 Dec; 84():103010. PubMed ID: 37852029
[TBL] [Abstract][Full Text] [Related]
17. A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy.
Alcantara KP; Malabanan JWT; Vajragupta O; Rojsitthisak P; Rojsitthisak P
J Drug Target; 2024 Jul; 32(6):587-605. PubMed ID: 38634290
[TBL] [Abstract][Full Text] [Related]
18. Microscopic investigation of" topically applied nanoparticles for molecular imaging of fresh tissue surfaces.
Kang S; Wang YW; Xu X; Navarro E; Tichauer KM; Liu JTC
J Biophotonics; 2018 Apr; 11(4):e201700246. PubMed ID: 29227576
[TBL] [Abstract][Full Text] [Related]
19. Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications.
Albert C; Bracaglia L; Koide A; DiRito J; Lysyy T; Harkins L; Edwards C; Richfield O; Grundler J; Zhou K; Denbaum E; Ketavarapu G; Hattori T; Perincheri S; Langford J; Feizi A; Haakinson D; Hosgood SA; Nicholson ML; Pober JS; Saltzman WM; Koide S; Tietjen GT
Nat Commun; 2022 Oct; 13(1):5998. PubMed ID: 36220817
[TBL] [Abstract][Full Text] [Related]
20. Peptide modified manganese-doped iron oxide nanoparticles as a sensitive fluorescence nanosensor for non-invasive detection of trypsin activity
Fu Y; Liu L; Li X; Chen H; Wang Z; Yang W; Zhang H; Zhang H
RSC Adv; 2021 Jan; 11(4):2213-2220. PubMed ID: 35424166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
